← All candidates
142 insider filings on record.
142 filings on record.
HOWLWerewolf Therapeutics, Inc.
NasdaqGS · Healthcare · $19.30M
$0.9800
+2.30% · Sep 15
142 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 142 sells◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$19.30M
Float
47.9M
99% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
0.9
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
4 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
137 more transactions on Pro →Context
Wall St
$4.00 avg target
+308.2% vs today · 1 analyst
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.28 act+$0.01
Q4 '25−$0.17 act+$0.18
Q3 '25−$0.36 act+$0.02
Q2 '25−$0.40 act−$0.03
Coverage
Here's Why We're A Bit Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn SituationSimply Wall St. · 05-14Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE ResultsInsider Monkey · 01-13Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should KnowZacks · 12-15Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's WhyZacks · 10-23
The file stays open
142 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice